loadpatents
name:-0.028373003005981
name:-0.020248889923096
name:-0.011635065078735
Josey; John A. Patent Filings

Josey; John A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Josey; John A..The latest application filed is for "methods of reducing inflammation of the digestive system with inhibitors of hif-2- alpha".

Company Profile
10.20.25
  • Josey; John A. - Dallas TX
  • JOSEY; JOHN A. - LONGMONT CO
  • Josey; John A. - Boulder CO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Of Reducing Inflammation Of The Digestive System With Inhibitors Of Hif-2- Alpha
App 20210015764 - Josey; John A. ;   et al.
2021-01-21
Aromatic compounds and uses thereof
Grant 10,807,948 - Dixon , et al. October 20, 2
2020-10-20
Combination therapy of a HIF-2-.alpha. inhibitor and an immunotherapeutic agent and uses thereof
Grant 10,786,480 - Josey , et al. September 29, 2
2020-09-29
Aryl Ethers And Uses Thereof
App 20200190031 - Dixon; Darryl David ;   et al.
2020-06-18
Aryl ethers and uses thereof
Grant 10,597,366 - Dixon , et al.
2020-03-24
Compositions for use in treating glioblastoma
Grant 10,512,626 - Josey Dec
2019-12-24
Combination Therapy Of A Hif-2-alpha Inhibitor And An Immunotherapeutic Agent And Uses Thereof
App 20190282535 - Josey; John A. ;   et al.
2019-09-19
Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
Grant 10,335,388 - Josey , et al.
2019-07-02
Compositions for use in treating pulmonary arterial hypertension
Grant 10,278,942 - Josey , et al.
2019-05-07
Aryl Ethers And Uses Thereof
App 20190119214 - Dixon; Darryl David ;   et al.
2019-04-25
Compositions for Use in Treating Pulmonary Arterial Hypertension
App 20190015377 - Dixon; Darryl David ;   et al.
2019-01-17
Aryl ethers and uses thereof
Grant 10,144,711 - Dixon , et al. De
2018-12-04
Benzimidazole derivatives and uses thereof
Grant 10,040,767 - Dixon , et al. August 7, 2
2018-08-07
Compositions For Use In Treating Pulmonary Arterial Hypertension
App 20180177754 - JOSEY; John A. ;   et al.
2018-06-28
Aromatic Compounds And Uses Thereof
App 20180162807 - DIXON; Darryl David ;   et al.
2018-06-14
Aryl Ethers And Uses Thereof
App 20180155279 - Dixon; Darryl David ;   et al.
2018-06-07
Combination Therapy Of A Hif-2-alpha Inhibitor And An Immunotherapeutic Agent And Uses Thereof
App 20180140569 - JOSEY; John A. ;   et al.
2018-05-24
Aryl ethers and uses thereof
Grant 9,969,689 - Dixon , et al. May 15, 2
2018-05-15
Aryl ethers and uses thereof
Grant 9,908,845 - Dixon , et al. March 6, 2
2018-03-06
Aryl ethers and uses thereof
Grant 9,896,418 - Dixon , et al. February 20, 2
2018-02-20
Compositions For Use In Treating Glioblastoma
App 20180042884 - JOSEY; John A.
2018-02-15
Cyclic sulfone and sulfoximine analogs and uses thereof
Grant 9,884,843 - Dixon , et al. February 6, 2
2018-02-06
Aryl Ethers And Uses Thereof
App 20170217892 - Dixon; Darryl David ;   et al.
2017-08-03
Aryl Ethers And Uses Thereof
App 20170217891 - Dixon; Darryl David ;   et al.
2017-08-03
Cyclic Sulfone And Sulfoximine Analogs And Uses Thereof
App 20160368893 - DIXON; Darryl David ;   et al.
2016-12-22
Aryl Ethers And Uses Thereof
App 20160251307 - DIXON; Darryl David ;   et al.
2016-09-01
Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
Grant 8,865,726 - Andrews , et al. October 21, 2
2014-10-21
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
App 20120178715 - Andrews; Steven W. ;   et al.
2012-07-12
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090286843 - BLATT; LAWRENCE M. ;   et al.
2009-11-19
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090111982 - Blatt; Lawrence M. ;   et al.
2009-04-30
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090111969 - Blatt; Lawrence M. ;   et al.
2009-04-30
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090105471 - Blatt; Lawrence M. ;   et al.
2009-04-23
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
Grant 7,022,690 - Koch , et al. April 4, 2
2006-04-04
Macrocyclic compounds as inhibitors of viral replication
App 20050267018 - Blatt, Lawrence M. ;   et al.
2005-12-01
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
App 20050159407 - Koch, Kevin ;   et al.
2005-07-21
Isocyano substituted polystyrene carbonate resin for use in 3 and 4 component condensation reactions
Grant 6,911,554 - Kennedy , et al. June 28, 2
2005-06-28
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
Grant 6,838,454 - Koch , et al. January 4, 2
2005-01-04
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
App 20040029863 - Koch, Kevin ;   et al.
2004-02-12
Isocyano substituted polystyrene carbonate resin for use in 3 and 4 component condensation reactions
App 20030225267 - Kennedy, April ;   et al.
2003-12-04
Substituted pyridine compounds and methods of use
Grant 6,458,813 - Mantlo , et al. October 1, 2
2002-10-01
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
App 20020065269 - Koch, Kevin ;   et al.
2002-05-30
Substituted pyridine compounds and methods of use
App 20020035094 - Mantlo, Nathan B. ;   et al.
2002-03-21
Substituted pyridine compounds and methods of use
Grant 6,333,341 - Mantlo , et al. December 25, 2
2001-12-25
Substituted pyridine compounds and methods of use
Grant 6,022,884 - Mantlo , et al. February 8, 2
2000-02-08
Company Registrations
SEC0001776351Josey John A.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed